Document Detail


Modification of the electrophysiologic matrix by antiarrhythmic drugs.
MedLine Citation:
PMID:  3923078     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Evidence from many experiments and observations suggests that the likelihood of ventricular fibrillation is increased in some proportion to the magnitude of local differences in the electrophysiologic state of the ventricular myocardium. Many local anesthetic antiarrhythmic drugs have differing affinities for resting, open and inactivated fast channels. In ischemic or otherwise damaged hearts, local differences in resting potential, action potential upstroke and action potential duration will result in differing degrees of block of fast channels by local anesthetic antiarrhythmic drugs. Such drugs can be expected to add to the preexisting local inhomogeneities of electrophysiologic state and thereby increase the likelihood of fibrillation.
Authors:
B F Hoffman
Related Documents :
18034998 - The cardiovascular safety profile of renzapride, a novel treatment for irritable bowel ...
8664528 - Interactions between antiarrhythmic drugs and implantable cardioverter-defibrillators.
6977958 - "torsades de pointes" invariant angina: successful treatment with verapamil.
365208 - The electrocardiogram in the assessment of the effect of drugs on cardiac arrhythmias.
23458068 - In vitro evaluation of enhancing effect of borneol on transcorneal permeation of compou...
11867518 - Shepherd is the arabidopsis grp94 responsible for the formation of functional clavata p...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  5     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  1985 Jun 
Date Detail:
Created Date:  1985-07-16     Completed Date:  1985-07-16     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  28B-30B     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Action Potentials / drug effects
Anti-Arrhythmia Agents / pharmacology*
Arrhythmias, Cardiac / physiopathology*
Benzocaine / pharmacology
Electrophysiology
Heart Conduction System / drug effects
Heart Rate / drug effects
Humans
Lidocaine / analogs & derivatives,  pharmacology
Time Factors
Tocainide
Ventricular Fibrillation / physiopathology
Grant Support
ID/Acronym/Agency:
HL-08508/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 137-58-6/Lidocaine; 41708-72-9/Tocainide; 94-09-7/Benzocaine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of left and right ventricular end-systolic pressure-volume relations in congestive heart ...
Next Document:  Regulation of cardiac vulnerability by the cerebral defense system.